Clinical Trial Update: Effects of Intranasal Nerve Growth Factor for Traumatic Brain Injury [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating intranasal nerve growth factor for traumatic brain injury has completed, with status updates from the sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Intranasal nerve growth factor (nerve growth factor)

Snippet

Sponsor: Jinling Hospital, China | Conditions: Traumatic Brain Injury | Phase 2 | Status: COMPLETED